Promomed's sales in January 2026 increased by 85% compared to the same period last year. Sales growth is due to the successful commercialization of key and basic drugs, the company notes. Share of revenue from the sale of innovative drugs was 61%. In 2026, the group plans to bring 8 more key drugs to the market.